Cargando…
Serum Epiplakin Might Be a Potential Serodiagnostic Biomarker for Bladder Cancer
SIMPLE SUMMARY: Improving early diagnosis and long-term postoperative monitoring of bladder cancer has become a focus of international research. In the present study, we evaluated the epiplakin expression levels in sera from patients with bladder cancer via a micro-dot blot array. Serum epiplakin le...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534213/ https://www.ncbi.nlm.nih.gov/pubmed/34680299 http://dx.doi.org/10.3390/cancers13205150 |